Hinge Bio
Burlingame
About Hinge Bio
Hinge Bio is a biotechnology company that specializes in leveraging its proprietary Flex-Hinge antibody platform to develop bispecific and multispecific antibodies. It features chemical ligation process technology that enables the production of therapeutic candidates with orders-of-magnitude improved affinity and specificity. The company was founded in 2015 and headquartered in Burlingame, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $30.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2025)
- Website: hingebio.com
- Phone: 650-488-7070
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/hinge-bio-34504 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.